Extramedullary acute myeloid leukaemia: isolated leukaemic pleural and pericardial effusions without marrow disease
Cutaneous thrombosis as the presenting finding of paroxysmal nocturnal haemoglobinuria
Platelet refractoriness – practical approaches and ongoing dilemmas in patient management
How we diagnose and treat essential thrombocythaemia
British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia
Optimizing the management of patients with spinal myeloma disease
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up
High-dose therapy improves the bone remodelling compartment canopy coverage and bone formation in multiple myeloma
Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma
Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions
Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease
Clinical features of venous insufficiency and the risk of venous thrombosis in older people
First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease
Frontline therapy of severe aplastic anaemia with fludarabine, cyclophosphamide and ciclosporin
Combination-therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron-loading in aceruloplasminaemia
MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia
Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012
Corrigendum